Meng GL - Search Results

1

Novel Therapeutic Potential of Retinoid-Related Orphan Receptor α in Cardiovascular Diseases.

Chen Y, Zhang SP, Gong WW, Zheng YY, Shen JR, Liu X, Gu YH, Shi JH, Meng GL. Chen Y, et al. Among authors: meng gl. Int J Mol Sci. 2023 Feb 9;24(4):3462. doi: 10.3390/ijms24043462. Int J Mol Sci. 2023. PMID: 36834872 Free PMC article. Review.

2

Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF β-Smad signal pathway.

Chen Y, Yang S, Yao W, Zhu H, Xu X, Meng G, Zhang W. Chen Y, et al. PLoS One. 2014 May 22;9(5):e98483. doi: 10.1371/journal.pone.0098483. eCollection 2014. PLoS One. 2014. PMID: 24852754 Free PMC article.

3

Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner.

Meng G, Yang S, Chen Y, Yao W, Zhu H, Zhang W. Meng G, et al. Pharm Biol. 2015 Jun;53(6):904-12. doi: 10.3109/13880209.2014.948635. Epub 2014 Dec 4. Pharm Biol. 2015. PMID: 25471017 Free article.

4

Dihydromyricetin Attenuates Myocardial Hypertrophy Induced by Transverse Aortic Constriction via Oxidative Stress Inhibition and SIRT3 Pathway Enhancement.

Chen Y, Luo HQ, Sun LL, Xu MT, Yu J, Liu LL, Zhang JY, Wang YQ, Wang HX, Bao XF, Meng GL. Chen Y, et al. Among authors: meng gl. Int J Mol Sci. 2018 Aug 31;19(9):2592. doi: 10.3390/ijms19092592. Int J Mol Sci. 2018. PMID: 30200365 Free PMC article.

5

Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin.

Zhang J, Chen Y, Luo H, Sun L, Xu M, Yu J, Zhou Q, Meng G, Yang S. Zhang J, et al. Front Pharmacol. 2018 Oct 25;9:1204. doi: 10.3389/fphar.2018.01204. eCollection 2018. Front Pharmacol. 2018. PMID: 30410442 Free PMC article. Review.

6

Exogenous Hydrogen Sulfide Supplement Attenuates Isoproterenol-Induced Myocardial Hypertrophy in a Sirtuin 3-Dependent Manner.

Zhang J, Yu J, Chen Y, Liu L, Xu M, Sun L, Luo H, Wang Y, Meng G. Zhang J, et al. Oxid Med Cell Longev. 2018 Dec 17;2018:9396089. doi: 10.1155/2018/9396089. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30647820 Free PMC article.

7

Ca²⁺/calmodulin-dependent protein kinase II regulation by inhibitor 1 of protein phosphatase 1 alleviates necroptosis in high glucose-induced cardiomyocytes injury.

Sun L, Chen Y, Luo H, Xu M, Meng G, Zhang W. Sun L, et al. Biochem Pharmacol. 2019 May;163:194-205. doi: 10.1016/j.bcp.2019.02.022. Epub 2019 Feb 16. Biochem Pharmacol. 2019. PMID: 30779910

8

Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor 1 of Protein Phosphatase 1 Protects Against Myocardial Ischemia-Reperfusion Injury.

Yu J, Chen Y, Xu M, Sun L, Luo H, Bao X, Meng G, Zhang W. Yu J, et al. J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):460-473. doi: 10.1177/1074248419841626. Epub 2019 Apr 28. J Cardiovasc Pharmacol Ther. 2019. PMID: 31030549

9

Inhibitor 1 of Protein Phosphatase 1 Regulates Ca²⁺/Calmodulin-Dependent Protein Kinase II to Alleviate Oxidative Stress in Hypoxia-Reoxygenation Injury of Cardiomyocytes.

Luo H, Song S, Chen Y, Xu M, Sun L, Meng G, Zhang W. Luo H, et al. Oxid Med Cell Longev. 2019 Dec 7;2019:2193019. doi: 10.1155/2019/2193019. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31885777 Free PMC article.

10

Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy.

Chen Y, Hua Y, Li X, Arslan IM, Zhang W, Meng G. Chen Y, et al. Front Pharmacol. 2020 Feb 7;11:42. doi: 10.3389/fphar.2020.00042. eCollection 2020. Front Pharmacol. 2020. PMID: 32116717 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters